Nephros, Inc. (NEPH) Financial Statements (2024 and earlier)

Company Profile

Business Address 380 LACKAWANNA PLACE
SOUTH ORANGE, NJ 07079
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,6346,9738,2494,1664,5812,194
Cash and cash equivalents3,6346,9738,2494,1664,5812,194
Receivables1,2861,6411,3641,0451,452836
Inventory, net of allowances, customer advances and progress billings3,1534,7955,3042,5621,864674
Inventory3,1534,7955,3042,5621,864674
Prepaid expense   141101  
Deferred costs     (1,312)(1,178)
Capital leases, lessor balance sheet, net investment in direct financing and sales type leases 20
Other current assets     27685
Other undisclosed current assets188225964251,3121,178
Total current assets:8,26113,63415,1548,2998,1733,809
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization12   
Operating lease, right-of-use asset972 1,0371,106
Property, plant and equipment116366295819152
Long-term investments and receivables      39
Capital leases, lessor balance sheet, net investment in direct financing and sales type leases 39
Intangible assets, net (including goodwill)1,5842,8311,9352,1111,3381,072
Goodwill759759759759748 
Intangible assets, net (excluding goodwill)8252,0721,1761,3525901,072
Other noncurrent assets548989321811
Other undisclosed noncurrent assets  730  938 
Total noncurrent assets:2,7384,0163,3563,3302,3851,174
TOTAL ASSETS:10,99917,65018,51011,62910,5584,983
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,0251,7787641,0951,2321,090
Accounts payable7401,334423959836872
Accrued liabilities285444341136396218
Debt792482401,0331,186711
Business combination, contingent consideration, liability    300236 
Deferred revenue and credits70
Other undisclosed current liabilities308364321   
Total current liabilities:1,4122,3901,3252,4282,6541,871
Noncurrent Liabilities
Long-term debt and lease obligation 4951,6051,502843954
Long-term debt, excluding current maturities  95846613843954
Finance lease, liability 4   
Liabilities, other than long-term debt700   263208
Deferred revenue and credits208
Operating lease, liability700 759889
Business combination, contingent consideration, liability     263 
Other undisclosed noncurrent liabilities 2416(752)10  
Total noncurrent liabilities:7065111,6121,5121,1061,162
Total liabilities:2,1182,9012,9373,9403,7603,033
Equity
Equity, attributable to parent5,59211,69512,5224,6753,7981,950
Common stock10101086455
Additional paid in capital148,413147,346144,296131,934127,816122,924
Accumulated other comprehensive income  6474657177
Accumulated deficit(142,831)(135,725)(131,858)(127,332)(124,153)(121,106)
Equity, attributable to noncontrolling interest 3,2893,0543,0513,0143,000 
Total equity:8,88114,74915,5737,6896,7981,950
TOTAL LIABILITIES AND EQUITY:10,99917,65018,51011,62910,5584,983

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues9,97510,4048,56110,3345,6873,809
Revenue, net3,809
Cost of revenue
(Cost of Goods and Services Sold)
(5,244)(4,661)(3,648)(4,250)(2,484)(1,517)
Gross profit:4,7315,7434,9136,0843,2032,292
Operating expenses(9,066)(10,078)(9,188)(9,239)(6,219)(4,518)
Operating loss:(4,335)(4,335)(4,275)(3,155)(3,016)(2,226)
Nonoperating income (expense)58468(152)(54)(35)(89)
Loss, foreign currency transaction, before tax      (19)
Other nonoperating income (expense)6417(152)(54)(35)(74)
Interest and debt expense(20)482(110)(195)(371)(302)
Loss from continuing operations before equity method investments, income taxes:(4,297)(3,385)(4,537)(3,404)(3,422)(2,617)
Other undisclosed income from continuing operations before income taxes   11 419
Loss from continuing operations before income taxes:(4,297)(3,385)(4,526)(3,404)(3,418)(2,598)
Income tax benefit    225931,789
Other undisclosed income from continuing operations20     
Loss from continuing operations:(4,277)(3,385)(4,526)(3,179)(3,325)(809)
Loss before gain (loss) on sale of properties:(3,385)(4,526)(3,179)(3,325)(809)
Loss from discontinued operations(2,829)     
Net loss:(7,106)(3,385)(4,526)(3,179)(3,325)(809)
Net loss attributable to noncontrolling interest(276)  (241)(77) 
Other undisclosed net loss attributable to parent  (482)    
Net loss attributable to parent:(7,382)(3,867)(4,526)(3,420)(3,402)(809)
Undistributed earnings (loss) allocated to participating securities, basic  (240)(240)   
Net loss available to common stockholders, diluted:(7,382)(4,107)(4,766)(3,420)(3,402)(809)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(7,106)(3,385)(4,526)(3,179)(3,325)(809)
Other undisclosed comprehensive income (loss)(14)(492)9(247)  
Comprehensive loss:(7,120)(3,877)(4,517)(3,426)(3,325)(809)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(276)(240)(240)241(77) 
Other undisclosed comprehensive income (loss), net of tax, attributable to parent     (6)10
Comprehensive loss, net of tax, attributable to parent:(7,396)(4,117)(4,757)(3,185)(3,408)(799)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: